Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Àrgentil Capital Management is a West African-focused investment firm that provides capital and advisory services to small and medium-sized enterprises (SMEs). While not a biotechnology or pharmaceutical developer itself, the firm is active in the healthcare sector through strategic investments in healthcare providers, pharmaceutical distribution, and related infrastructure. Àrgentil manages funds like the Àrgentil Principal Investment Portfolio II (APIP II), targeting growth opportunities in Nigeria and the broader West African region. Their involvement in healthcare aims to improve access to quality medical services and supply chain efficiency in emerging markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Àrgentil Capital Management.